Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

0(0%)

Results Posted

80%(4 trials)

Terminated

1(17%)

Phase Distribution

Ph not_applicable

17%

Ph phase_1

17%

Ph phase_2

50%

Ph early_phase_1

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Early Phase 1First-in-human

1(16.7%)

Phase 1Safety & dosage

1(16.7%)

Phase 2Efficacy & side effects

3(50.0%)

N/ANon-phased studies

1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(1)

Detailed Status

Completed5

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 2

Trials by Phase

Early Phase 11 (16.7%)

Phase 11 (16.7%)

Phase 23 (50.0%)

N/A1 (16.7%)

Trials by Status

terminated117%

completed583%

Recent Activity

0 active trials

Showing 5 of 6

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT03267758Not Applicable

Effect of Probiotic Supplementation on Endothelial Function II

Completed

NCT05259943Phase 2

Microdosing Psychedelics to Improve Mood

Completed

NCT03612713Early Phase 1

Influence of Medication on Functional Connectivity

Completed

NCT01237041Phase 1

Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children

Terminated

NCT01740414Phase 2

Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers

Completed

NCT00934362Phase 2

Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6